You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LDL choelsterol

Showing 1 - 25 of 1,261
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)

Active, not recruiting
  • Coronary Artery Diseasse
  • fixed high potent statin therapy
  • targeted LDL-C goal statin
  • Seoul, Korea, Republic of
    Division of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022

Hypercholesterolemia, Primary Prevention Trial in Sao Paulo (Phytosterol supplements)

Completed
  • Hypercholesterolemia
  • Primary Prevention
  • Phytosterol supplements
  • Sao Paulo, Other, Brazil
  • +1 more
Nov 9, 2023

Healthy Trial (Mango, vanilla wafers)

Not yet recruiting
  • Healthy
  • Mango
  • vanilla wafers
  • (no location specified)
Sep 7, 2023

Oxidized Low Density Lipoprotein Trial in Fort Lauderdale (Cardio formulation, Placebo)

Terminated
  • Oxidized Low Density Lipoprotein
  • Cardio formulation
  • Placebo
  • Fort Lauderdale, Florida
    Lfie Extension Clinical Reseach, Inc.
Jan 12, 2023

ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

Not yet recruiting
  • ASCVD
  • Coronary Artery Calcification
  • Notification of patients and clinicians
  • (no location specified)
May 5, 2023

LDL-Apheresis for FSGS CardioRenal Outcomes

Enrolling by invitation
  • Focal Segmental Glomerulosclerosis
  • No intervention
  • Cincinnati, Ohio
  • +1 more
Jan 25, 2023

Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
  • Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
  • (no location specified)
Mar 14, 2023

Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid), Placebo)

Recruiting
  • Hyper-low-density Lipoprotein (LDL) Cholesterolemia
  • 180mg of ETC-1002(bempedoic acid)
  • Placebo
  • Izumisano-shi, Japan
    Rinku General Medical Center
Jan 4, 2023

Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebos)

Active, not recruiting
  • Acute Coronary Syndrome
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Dec 8, 2022

Abdominal Aortic Aneurysm Trial (Evolocumab, Placebo)

Not yet recruiting
  • Abdominal Aortic Aneurysm
  • (no location specified)
Oct 12, 2023

Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)

Active, not recruiting
  • Above Optimal Plasma LDL Concentrations
  • muffin
  • Winnipeg, Manitoba, Canada
  • +1 more
Oct 24, 2022

Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)

Enrolling by invitation
  • Hypercholesterolemia
  • Atherosclerotic Ischemic Disease
  • Nantes, Cedex 01, France
  • +6 more
Nov 3, 2022

Acute Coronary Syndrome Trial in United States (Inclisiran)

Recruiting
  • Acute Coronary Syndrome
  • Huntsville, Alabama
  • +77 more
Jan 13, 2023

COVID-19 Trial in Houston (COVID-19 Group Problem Solving, Standard of Care, Booster session)

Recruiting
  • COVID-19
  • COVID-19 Group Problem Solving
  • +2 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Nov 22, 2023

Endometriosis Trial in University Park (Salsalate Pill, Placebo)

Recruiting
  • Endometriosis
  • Salsalate Pill
  • Placebo
  • University Park, Pennsylvania
    The Pennsylvania State University
Dec 13, 2022

Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Sale, Cheshire, United Kingdom
  • +16 more
Jan 20, 2023

Cardiovascular Disease Trial in Seoul (Intensive targeting group, Conventional therapy group)

Recruiting
  • Cardiovascular Disease
  • Intensive targeting group
  • Conventional therapy group
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Oct 7, 2022

Cardiovascular Diseases, Atherosclerosis, Dyslipidemias Trial (Digitally-enabled Multifaceted Quality Improvement Intervention,

Not yet recruiting
  • Cardiovascular Diseases
  • +2 more
  • Digitally-enabled Multifaceted Quality Improvement Intervention
  • Usual care
  • (no location specified)
Nov 14, 2022

Cardiovascular Diseases, Hyper-LDL-cholesterolemia Trial in Cincinnati (lerodalcibep)

Active, not recruiting
  • Cardiovascular Diseases
  • Hyper-LDL-cholesterolemia
  • Cincinnati, Ohio
  • +2 more
Nov 3, 2022

Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke Trial in India, Israel, United States (lerodalcibep,

Active, not recruiting
  • Cardiovascular Risk Factor
  • +3 more
  • Cincinnati, Ohio
  • +5 more
Nov 3, 2022

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Acute Coronary Syndrome, Myocardial Infarction, Ischemic Stroke Trial in Dudley (Decision Support System (DSS))

Recruiting
  • Acute Coronary Syndrome
  • +2 more
  • Decision Support System (DSS)
  • Dudley, West Midlands, United Kingdom
    Russell's Hall Hospital
Apr 25, 2023

Hyperlipidemic Trial (SHR-1918, SHR-1918 )

Not yet recruiting
  • Hyperlipidemic
  • (no location specified)
Oct 26, 2023

Hyperlipidemias, Dyslipidemias Trial (Obicetrapib)

Not yet recruiting
  • Hyperlipidemias
  • Dyslipidemias
  • (no location specified)
Aug 2, 2023

Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)

Active, not recruiting
  • Heterozygous Familial Hypercholesterolemia
  • Cincinnati, Ohio
  • +6 more
Nov 3, 2022